Li Letai

Dr. Li Letai


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LLLi Letai
Li Letai
YZYaowen Zhang
Yaowen Zhang
JLJiajie Leng
Jiajie Leng
SLSiyu Li
Siyu Li
YLYang Lei
Yang Lei
YJYingjiu Jiang
Yingjiu Jiang
Background: Alcohol use is a major risk factor for pancreatitis and global mortality. Despite its impact, comprehensive analyses of the burden across regions and sociodemographic strata remain scarce. This study examines global trends (1990–2021) and projects future burdens to 2040. Method: Data on Deaths and Disability-Adjusted Life Years (DALYs) attributable to alcohol-induced pancreatitis were retrieved from the 2021 iteration of the Global Burden of Diseases (GBD) database. Trends were analyzed, Age-Period-Cohort models quantified age, period, and cohort effects on Age-Standardized Mortality Rate (ASMR) and Age-Standardized Disability-Adjusted Life Year (ASDR). Associations with SDI were evaluated, burden decomposition applied, and projections made to 2040. Results: Globally, both age-standardized death rate (ASDR) and mortality ratio (ASMR) exhibited overall declines (EAPC for ASDR: −0.32%; ASMR: −0.27%), but the reduction was significantly smaller in males (ASDR-EAPC: −0.18%) compared to females (−1.34%). Notablly,Eastern Europe had the highest burden (ASDR: 64.03), High-income Asia-Pacific saw the largest declines (EAPC for ASDR: −2.45%; EAPC for ASMR: −2.96%), while Southeast Asia experienced the fastest increase (EAPC for ASDR: 1.98%; EAPC for ASMR: 2.13%). ASDR peaked at ages 45–49, with high-middle SDI countries showing the highest values. Period and cohort effects varied by SDI, with downward trends in high SDI countries and upward trends in lower SDI groups. Population growth and aging drove increases in deaths and DALYs, while epidemiologic changes reduced them. By 2040, deaths and DALYs will stabilize, ASMR will decline until 2034 then rise, and ASDR will decrease until 2035 then increase, driven by population growth. Conclusion: Alcohol-related pancreatitis burden demonstrates striking gender, age, and geographic heterogeneity. Targeted policies for high-risk groups (middle-aged/elderly males) and regions (Eastern Europe, Low-middle SDI countries), coupled with preparedness for aging-related burden escalation, are urgently needed.

24 May 2024 in Medicine
Verified
Journal Article
Open access
JLJiajie Leng
Jiajie Leng
LLLi Letai
Li Letai
HTHongwen Tu
Hongwen Tu
YLYuxiang Luo
Yuxiang Luo
ZCZhenrui Cao
Zhenrui Cao
YJYingjiu Jiang
Yingjiu Jiang
Acute kidney injury (AKI) is a common postoperative complication, but there is still a lack of accurate biomarkers. Cardiac surgery-associated AKI is the most common cause of major-surgery-related AKI, and patients requiring renal replacement therapy have high mortality rates. Early diagnosis, intervention, and management are crucial for improving patient prognosis. However, diagnosing AKI based solely on changes in serum creatinine level and urine output is insufficient, as these changes often lag behind actual kidney damage, making early detection challenging. Biomarkers such as tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor-binding protein-7 (IGFBP-7) have been found to be significant predictors of moderate-to-severe AKI when combined with urine content analysis. This article reviews the mechanism of biomarkers TIMP-2 and IGFBP-7 in AKI and provides a comprehensive overview of the clinical effects of TIMP-2 and IGFBP-7 in cardiac surgery-associated AKI, including prediction, diagnosis, and progression.


8 June 2025 in Archives of Medical Science
Verified
Journal Article
Open access
ZXZhaohui Xu
Zhaohui Xu
LLLi Letai
Li Letai
YHYinqin Hu
Yinqin Hu
JYJiahui Yang
Jiahui Yang
QWQiqi Wan
Qiqi Wan
YLYongming Liu
Yongming Liu
Introduction: This study aimed to evaluate trends in HHD mortality attributable to HBMI from 1990 to 2021 and projections up to 2040.Material and methods: Data on HHD mortality attributable to HBMI were obtained from the Global Burden of Diseases (GBD) 2021 database. Temporal trends in the burden of HHD attributable to HBMI were analyzed using generalized linear models to calculate the estimated annual percentage change (EAPC) in age-standardized mortality rates (ASMR) and age-standardized disability-adjusted life-years (DALYs) rates (ASDR) from 1990 to 2021.Results: From 1990 to 2021, the global ASMR for HHD attributable to HBMI increased from 6.83 (4.37 - 9.32) to 7.21 (4.23 - 9.94), with an EAPC value of 0.33 (0.27 - 0.39) for the ASMR. the ASDR increased from 144.72 (106.21 - 182.76) to 147.33 ( 109.06 - 183.45) with an EAPC value of 0.15 (0.1 - 0.21) for ASDR. Particularly severe ASMR and ASDR were observed in most countries in Africa and in a few countries along the Mediterranean coast. In contrast, most developed countries in North America, Europe, and Australia presented lower ASMR and ASDR. When the overall trend was divided into subsections, at the end of the study period, ASMR and ASDR for HHD attributable to HBMI showed a downward trend. By dividing the regions by SDI, middle SDI had the greatest fluctuation in ASMR and ASDR, and low SDI showed an increasing trend in ASMR and ASDR at the final joinpoint.Conclusions: Therefore, more targeted prevention approaches should be established to mitigate this growing trend.

30 October 2025 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
ZCZhenrui Cao
Zhenrui Cao
HWHaiyan Wang
Haiyan Wang
YLYanlin Li
Yanlin Li
SYSiying Ye
Siying Ye
JLJingyao Lin
Jingyao Lin
LLLi Letai
Li Letai
Esophageal cancer (EC) ranks 7th globally in cancer mortality, with smoking being a major preventable risk factor, particularly for squamous cell carcinoma predominant in Asia. This study quantifies the global burden of smoking-attributable EC among males using 2021 Global Burden of Disease data (1990–2021) and projects trends to 2040. Data on deaths and Disability-Adjusted Life Years (DALYs) for global burden of smoking-attributable EC among males were derived from the Global Burden of Diseases (GBD) Study 2021, along with the corresponding 95% uncertainty intervals (UIs). We analyzed with Joinpoint regression, age-period-cohort modeling for risk stratification, decomposition analysis, and Bayesian prediction. Global smoking-attributable EC deaths and DALYs among males decreased, concentrated in middle-to-high SDI regions. Age-standardized DALY rates (ASDR) declined significantly, with sharpest reductions in medium-SDI regions. East Asia bore disproportionate burden in China and Mongolia. Critical inflection occurred in 2004 by joinpoint and age-period-cohort analysis from 1990 to 2021. Mortality peak at 80–90 years and disability peak at 60–80 years. Decomposition analysis showed population growth and aging increased burden, offset by epidemiological improvements. Predictive analysis indicated stable-to-declining ASRs through 2040, contingent on sustained tobacco control in high-risk regions. The analysis indicated a global downward trend in EC attributable to smoking among males. While absolute burdens rise due to demographic pressures, declining ASRs reflect tobacco control progress. The 2004 inflection underscores policy impact, and East Asia's outsized burden necessitates targeted interventions. Our research underscores the profound influence of high BMI on EC attributable to smoking among males and provides a research foundation for future public health decision-making.

26 July 2024 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
HXHaibing Xiong
Haibing Xiong
RJRan Jiang
Ran Jiang
LXLingzhi Xing
Lingzhi Xing
JZJiaojiao Zheng
Jiaojiao Zheng
XTXinhong Tian
Xinhong Tian
LLLi Letai
Li Letai
Background: Previous observational clinical studies and meta-analyses have yielded inconsistent results regarding the relationship between vitamin D and headache, and the causal relationship remains unclear. The aim of this study was to investigate the causal relationship between vitamin D and headache by bidirectional two-sample Mendelian randomisation (MR) analysis.Methods: The relationship between high levels of vitamin D and headache was investigated by two-sample MR analysis using publicly available genome-wide association study (GWAS) data. The primary method was inverse variance weighting (IVW), and secondary methods were weighted median and MR-Egger methods. No heterogeneity or horizontal multidirectionality was found in the MR results. The robustness and validity of the findings were assessed using the leave-behind method.Results: A significant causal relationship was found between high vitamin D levels and headache using the IVW method (OR = 0.848; p = 0.007; 95% CI = 0.752–0.956). However, in a reverse analysis, no evidence of a causal relationship between headache and high levels of vitamin D was found using the IVW method (OR = 1.001; p = 0.906; 95% CI = 0.994–1.006). Our MR analyses showed no significant horizontal multidimensionality or heterogeneity (p > 0.05). Sensitivity analyses confirmed that MR estimates were not affected by single nucleotide polymorphisms (SNPs). Confirmation that our results are robust and valid has been obtained by the leave-one-out method.Conclusion: Our study suggests that high levels of vitamin D prevent the risk of headache. However, there is no evidence of a causal relationship between headache and high levels of vitamin D. Vitamin D may reduce the risk of headache.